BRANDON STILL: Open Payments
NPI 1215408604 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 49 payments from 17 companies in 2025. Trend: 2023 $979 · 2024 $851 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $235 |
| AstraZeneca Pharmaceuticals LP | 5 | $144 |
| Novo Nordisk Inc | 8 | $137 |
| Exact Sciences Corporation | 4 | $77 |
| PFIZER INC. | 3 | $62 |
| GlaxoSmithKline, LLC. | 2 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Amgen Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
Products named: Ozempic, QULIPTA, VRAYLAR, Cologuard Collection Kit, AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, XIFAXAN.
Industry payments across FL — which companies pay providers there.
